Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus
Completed
- Conditions
- T2DM (Type 2 Diabetes Mellitus)Hypogonadism
- Registration Number
- NCT03437109
- Lead Sponsor
- Besins Healthcare
- Brief Summary
The purpose of the study is to get data of prevalence of testosterone deficiency in patient with T2DM in Russian Federation
- Detailed Description
Clinical and Epidemiological Characteristics and Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus Under Routine Clinical Practice (DESTINY)
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 554
Inclusion Criteria
- Male 45-60 years old
- Diagnosis of T2DM according to approved standards
- Signed Informed Consent Form
Exclusion Criteria
- Prepubertal hypogonadism of any genesis;
- Sexual and developmental disorders;
- Absence of at least one of the testicles;
- Cryptorchidism, including in the anamnesis;
- Injuries and / or surgical interventions on the genitals with loss of at least one of the testicles;
- Established diagnosis of panhypopituitarism in accordance with current recommendations / standards;
- Androgen therapy, administered at the time of the study or in the anamnesis;
- Admission of anabolic steroids;
- Alcoholism or drug addiction;
- Insolvency.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The prevalence of hypogonadism in patients with T2DM 2017-2018 The prevalence of hypogonadism in patients with T2DM
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
ENC
🇷🇺Moscow, Russian Federation
Central Clinical Hospital
🇷🇺Moscow, Russian Federation